Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis.

TitleVenetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis.
Publication TypeJournal Article
Year of Publication2020
AuthorsBewersdorf JPhilipp, Giri S, Wang R, Williams RT, Tallman MS, Zeidan AM, Stahl M
JournalHaematologica
Date Published2020 Jan 23
ISSN1592-8721
DOI10.3324/haematol.2019.242826
Alternate JournalHaematologica
PubMed ID31974201

Person Type: